Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan Plc -1.04%175.702.9%$874.53m
ZTSZoetis, Inc. -1.25%114.581.9%$437.14m
TEVATeva Pharmaceutical Industries Ltd. 3.57%8.412.0%$204.08m
MYLMylan NV -1.29%13.743.2%$131.49m
BBIOBridgeBio Pharma, Inc. -10.19%22.220.0%$38.08m
RDYDr. Reddy's Laboratories Ltd. 1.68%41.142.0%$9.60m
TAROTaro Pharmaceutical Industries Ltd. 1.62%63.416.5%$4.06m
TXMDTherapeuticsMD, Inc. -7.97%0.9222.2%$3.89m
COCPCocrystal Pharma, Inc. -1.43%0.710.0%$3.69m
ABEOAbeona Therapeutics, Inc. -0.95%2.094.5%$3.38m
LFVNLifeVantage Corp. 2.20%10.713.3%$1.19m
KINKindred Biosciences, Inc. -10.16%3.450.3%$0.92m
CPHIChina Pharma Holdings, Inc. 0.77%0.410.1%$0.74m
JAGXJaguar Health, Inc. 6.32%0.512.2%$0.17m

Company Profile

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.